These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3721503)

  • 21. Xp21 contiguous gene syndromes: deletion quantitation with bivariate flow karyotyping allows mapping of patient breakpoints.
    McCabe ER; Towbin JA; van den Engh G; Trask BJ
    Am J Hum Genet; 1992 Dec; 51(6):1277-85. PubMed ID: 1463011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy.
    Chelly J; Marlhens F; Le Marec B; Jeanpierre M; Lambert M; Hamard G; Dutrillaux B; Kaplan JC
    Hum Genet; 1986 Oct; 74(2):193-6. PubMed ID: 2876949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy.
    Monaco AP; Bertelson CJ; Colletti-Feener C; Kunkel LM
    Hum Genet; 1987 Mar; 75(3):221-7. PubMed ID: 2881877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombination outside the BB deletion refines the location of the X linked retinitis pigmentosa locus RP3.
    Fujita R; Bingham E; Forsythe P; McHenry C; Aita V; Navia BA; Dry K; Segal M; Devoto M; Bruns G; Wright AF; Ott J; Sieving PA; Swaroop A
    Am J Hum Genet; 1996 Jul; 59(1):152-8. PubMed ID: 8659520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The screening of Duchenne muscular dystrophy patients for submicroscopic deletions.
    Hart K; Cole C; Walker A; Hodgson S; Johnson L; Dubowitz V; Ray P; Worton R; Bobrow M
    J Med Genet; 1986 Dec; 23(6):516-20. PubMed ID: 3806637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion mapping of Aland Island eye disease to Xp21 between DXS67 (B24) and Duchenne muscular dystrophy.
    Pillers DA; Towbin JA; Chamberlain JS; Wu D; Ranier J; Powell BR; McCabe ER
    Am J Hum Genet; 1990 Nov; 47(5):795-801. PubMed ID: 2220819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA deletions in mild and severe Becker muscular dystrophy.
    Hart KA; Hodgson S; Walker A; Cole CG; Johnson L; Dubowitz V; Bobrow M
    Hum Genet; 1987 Mar; 75(3):281-5. PubMed ID: 3030926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular biology in diagnosis and detection of deletion in Duchenne muscular dystrophy].
    Graninger W; Wintersberger W; Meron G; Smolen J; Toifl K; Vormittag W
    Wien Klin Wochenschr; 1991; 103(7):207-9. PubMed ID: 2063586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial inheritance of a DXS164 deletion mutation from a heterozygous female.
    Lanman JT; Pericak-Vance MA; Bartlett RJ; Chen JC; Yamaoka L; Koh J; Speer MC; Hung WY; Roses AD
    Am J Hum Genet; 1987 Aug; 41(2):138-44. PubMed ID: 2887110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial deletion in Becker type muscular dystrophy within the pXJ region.
    Liechti-Gallati S; Braga S; Hirsiger H; Moser H
    Hum Genet; 1987 Nov; 77(3):267-8. PubMed ID: 2890571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localisation of Xp21 meiotic exchange points in Duchenne muscular dystrophy families.
    Bertelson CJ; Bartley JA; Monaco AP; Colletti-Feener C; Fischbeck K; Kunkel LM
    J Med Genet; 1986 Dec; 23(6):531-7. PubMed ID: 2879924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.
    Monaco AP; Neve RL; Colletti-Feener C; Bertelson CJ; Kurnit DM; Kunkel LM
    Nature; 1986 Oct 16-22; 323(6089):646-50. PubMed ID: 3773991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial occurrence of Duchenne dystrophy through paternal lines in four families.
    Zatz M; Passos-Bueno MR; Rapaport D; Vainzof M
    Am J Med Genet; 1991 Jan; 38(1):80-4. PubMed ID: 1849353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential deletion of exons in Duchenne and Becker muscular dystrophies.
    Forrest SM; Cross GS; Speer A; Gardner-Medwin D; Burn J; Davies KE
    Nature; 1987 Oct 15-21; 329(6140):638-40. PubMed ID: 2821406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype.
    de Saint-Basile G; Bohler MC; Fischer A; Cartron J; Dufier JL; Griscelli C; Orkin SH
    Hum Genet; 1988 Sep; 80(1):85-9. PubMed ID: 3417309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular deletion analysis in Duchenne muscular dystrophy.
    Thomas NS; Ray PN; Worton RG; Harper PS
    J Med Genet; 1986 Dec; 23(6):509-15. PubMed ID: 2879923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions.
    Francke U; Harper JF; Darras BT; Cowan JM; McCabe ER; Kohlschütter A; Seltzer WK; Saito F; Goto J; Harpey JP
    Am J Hum Genet; 1987 Mar; 40(3):212-27. PubMed ID: 2883886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular deletion patterns in Duchenne muscular dystrophy patients.
    Lucotte G; David F; Levy C
    Ann Genet; 1989; 32(4):214-9. PubMed ID: 2610487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aland Island eye disease (Forsius-Eriksson ocular albinism) and an Xp21 deletion in a patient with Duchenne muscular dystrophy, glycerol kinase deficiency, and congenital adrenal hypoplasia.
    Pillers DA; Weleber RG; Powell BR; Hanna CE; Magenis RE; Buist NR
    Am J Med Genet; 1990 May; 36(1):23-8. PubMed ID: 2159212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.
    Ho MF; Monaco AP; Blonden LA; van Ommen GJ; Affara NA; Ferguson-Smith MA; Lehrach H
    Am J Hum Genet; 1992 Feb; 50(2):317-30. PubMed ID: 1734714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.